IL1A and Alzheimer disease: In 3D AD models, topical celastrol (10 μM) was well tolerated and markedly reduced secretion of IL-8, IL-6, IL-1α, and mRNA expression of CXCL8, IL6, IL1B, and IL23A, even under continuous Th2 stimulation.